Sign in

Labroots Biotech & Pharma Sciences

@biotech-lr.bsky.social
10 followers 1 following 85 posts

The Official @labroots.bsky.social Biotech & Pharma Page! Here for facts, events, videos, papers, and much more.

PostsRepliesMedia
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 54m
Looking to modernize your pharmaceutical QA/QC lab? Discover practical ways to simplify workflows, improve processes, and prepare for future technologies with this helpful guide. buff.ly/LDpLIvu
labroots.com
How to Modernize Pharmaceutical QA/QC Laboratories - A Guide
000
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 09/10/2026
Teva wins FDA approval for Weltruza, the first once-monthly subcutaneous olanzapine injection for adults with schizophrenia. buff.ly/LbewnXO
labroots.com
https://www.labroots.com/trending/biotech-and-pharma/31195/teva-wins-fda-approval-monthly-schizophrenia-injection
000
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 09/10/2026
Pfizer’s Tukysa wins FDA approval for first-line maintenance treatment of HER2-positive metastatic breast cancer. buff.ly/0cr2xSG
labroots.com
https://www.labroots.com/trending/biotech-and-pharma/31194/pfizer-s-tukysa-approved-first-line-her2-breast-cancer
000
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 09/10/2026
Not all multiplex immunofluorescence technologies are designed for the same objective. This guide compares the main categories and explains which workflows are best for discovery, biomarker development, and clinical research. buff.ly/6xVZBFh
labroots.com
Multiplex Immunofluorescence: Matching the Technology to Your Research Goal
000
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 06/10/2026
Gene‑modified CAR T cell therapies are transforming cancer treatment, but variability and manufacturing challenges remain. Discover high‑throughput strategies to characterize CAR T cells—activation, memory, exhaustion, cytokines, and killing. buff.ly/kbahSQo
labroots.com
Phenotypic and Functional Characterization of CAR-T Cells to Support Robust Cell Therapy Research
000
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 02/10/2026
Could poor pipetting ergonomics be slowing your lab down? Learn how the right equipment and workflow choices can reduce fatigue, support accuracy and help scientists work more comfortably. Download INTEGRA Biosciences’ free eBook. buff.ly/a5MSqic
labroots.com
The Practical Guide to Ergonomic Liquid Handling
000
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 01/10/2026
A new laser-based technique detects the colorectal cancer biomarker CEACAM-5 in blood plasma within minutes, offering much faster results than conventional methods. buff.ly/wUkEBh3
labroots.com
Laser tech detects colorectal cancer biomarker in minutes
000
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 29/09/2026
Modernizing a pharma QA/QC laboratory is about more than replacing a LIMS. Discover how to reduce complexity, standardize processes, prepare for AI and emerging technologies, and build a foundation for long-term value in this new practical guide. buff.ly/F12KTiq
labroots.com
Modernizing pharmaceutical QA/QC laboratories
001
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 28/09/2026
The FDA has approved Gilead’s Bixlenvo, a new once-daily combination pill for adults with virologically suppressed HIV. The treatment combines bictegravir and lenacapavir. www.labroots.com/trending/bio...
labroots.com
https://www.labroots.com/trending/biotech-and-pharma/30975/fda-approves-gilead-s-once-daily-hiv-pill-bixlenvo
000
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 27/09/2026
The FDA has approved Lisraya, the first targeted therapy for adults with dermatomyositis. www.labroots.com/trending/bio...
labroots.com
https://www.labroots.com/trending/biotech-and-pharma/30977/fda-approves-targeted-therapy-rare-skin-disease
000
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 25/09/2026
The FDA has approved lirafugratinib (Lyrfigtu) for previously treated advanced cholangiocarcinoma with FGFR2 fusions or rearrangements. buff.ly/I603iRj
labroots.com
https://www.labroots.com/trending/biotech-and-pharma/31111/fda-approves-lirafugratinib-advanced-bile-duct-cancer
000
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 25/09/2026
Discover how genetic analysis technologies are helping biopharmaceutical organizations optimize clinical trials, improve patient stratification, and accelerate drug development. buff.ly/n1lHkFs
labroots.com
How Genetic Analysis Accelerates Clinical Development
000
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 21/09/2026
A 4D AI model uses mitochondrial shape and movement to predict how drugs affect cells, potentially speeding up drug discovery. buff.ly/DQ9lwvB
labroots.com
4D AI Model Decodes Mitochondrial Drug Effects
000
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 21/09/2026
How is genetic analysis shaping the future of biopharmaceutical development? Explore how biomarkers, patient selection, and advanced molecular technologies can support more efficient clinical trials and precision medicine. Download the free white paper: buff.ly/n1lHkFs
labroots.com
How Genetic Analysis Accelerates Clinical Development
000
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 18/09/2026
Bringing a diagnostic test to market takes more than scientific innovation. Explore the reimbursement, evidence, coding, coverage, and payment strategies that support successful adoption in the US. buff.ly/SN7fRZ3
labroots.com
LDT and IVD Reimbursement: A Guide to US Market Access
000
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 18/09/2026
Could poor pipetting ergonomics be slowing your lab down? Learn how the right equipment and workflow choices can reduce fatigue, support accuracy and help scientists work more comfortably. Download INTEGRA Biosciences’ free eBook. buff.ly/IxxYmGm
labroots.com
The Practical Guide to Ergonomic Liquid Handling
000
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 18/09/2026
The FDA has approved Fayuvi, the first gene therapy for children with rare neurodegenerative disorder, Sanfilippo syndrome type A. buff.ly/MrX4BMn
labroots.com
https://www.labroots.com/trending/biotech-and-pharma/31075/fda-oks-gene-therapy-rare-neurodegenerative-disorder
000
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 17/09/2026
Healthcare AI is advancing faster than patient understanding, creating a growing gap in digital health literacy. buff.ly/Q0TUGp2
labroots.com
Healthcare AI moves faster than patient literacy evidence
000
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 16/09/2026
Struggling with iPSC culture consistency? Discover a semi-automated workflow for stem cell selection, live-cell monitoring, and 3D spheroid generation that helps reduce variability and support robust advanced cell model development. Download the app note: buff.ly/yh7hbWY
labroots.com
Semi-Automated iPSC Culture and 3D Cell Model Generation
000
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 15/09/2026
Modernizing a pharma QA/QC laboratory is about more than replacing a LIMS. Discover how to reduce complexity, standardize processes, prepare for AI and emerging technologies, and build a foundation for long-term value in this new practical guide. buff.ly/GK5j4HW
labroots.com
Modernizing pharmaceutical QA/QC laboratories
000
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 11/09/2026
Novo Nordisk’s Wegovy helped 40.4% of children with obesity fall below the clinical obesity threshold after 68 weeks in a phase 3 trial. buff.ly/4FPmuQJ
labroots.com
https://www.labroots.com/trending/biotech-and-pharma/31042/wegovy-promise-children-obesity
000
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 11/09/2026
FDA expands Bayer’s Hyrnuo approval to first-line treatment for HER2-mutated NSCLC, after the drug showed a 75% response rate in previously untreated patients. buff.ly/lRXt0XI
labroots.com
https://www.labroots.com/trending/biotech-and-pharma/31041/fda-expands-hyrnuo-her2-mutated-lung-cancer
001
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 10/09/2026
Antihistamines may offer little meaningful relief for eczema, while some may increase sedation and cognitive impairment. buff.ly/s9w7miz
labroots.com
https://www.labroots.com/trending/health-sciences-and-medical-research/31034/antihistamines-offer-little-relief-eczema
000
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 09/09/2026
Tadalafil (Cialis) was associated with a higher risk of glaucoma and ocular hypertension in men, according to new research. buff.ly/6oEMECh
labroots.com
https://www.labroots.com/trending/drug-discovery/31024/cialis-linked-glaucoma-risk
000
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 09/09/2026
Semaglutide was linked to nearly 40% fewer asthma attacks and 20% fewer COPD flare-ups in a large real-world study. buff.ly/bloTXEL
labroots.com
https://www.labroots.com/trending/drug-discovery/31023/semaglutide-linked-fewer-asthma-attacks
000
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 08/09/2026
Learn how to advance your upstream strategy with expert insights from the BioPro Materials Virtual Summit, hosted by Thermo Fisher Scientific. Explore cell culture optimization, process intensification, scale-up, and more. September 29. Register: www.labroots.com/ms/virtual-e...
000
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 31/08/2026
The FDA has approved Gilead’s Bixlenvo, a new once-daily combination pill for adults with virologically suppressed HIV. The treatment combines bictegravir and lenacapavir. www.labroots.com/trending/bio...
labroots.com
https://www.labroots.com/trending/biotech-and-pharma/30975/fda-approves-gilead-s-once-daily-hiv-pill-bixlenvo
000
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 28/08/2026
The FDA has approved Lisraya, the first targeted therapy for adults with dermatomyositis. www.labroots.com/trending/bio...
labroots.com
https://www.labroots.com/trending/biotech-and-pharma/30977/fda-approves-targeted-therapy-rare-skin-disease
000
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 24/08/2026
The FDA approved Pasatru to significantly reduce abnormal bone formation in adults with the rare genetic disorder FOP. www.labroots.com/trending/bio...
labroots.com
FDA Approves Pasatru for Rare Bone-Forming Disorder | Biotech And Pharma
The FDA has approved Regeneron's Pasatru to reduce the formation of new abnormal bone and clinician-assessed flare-ups in adults with FOP. | Biotech And Pharma
000
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 20/08/2026
Obsidian Therapeutics merged with Galera Therapeutics, securing $350 million to advance its engineered cell therapy pipeline through 2028. www.labroots.com/trending/bio...
labroots.com
Obsidian Therapeutics Merges with Galera Therapeutics | Biotech And Pharma
The clinical-stage biopharmaceutical company Obsidian Therapeutics finalized a transaction that brings Galera Therapeutics under the Obsidian name. Before | Biotech And Pharma
010
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 20/08/2026
A common class of blood pressure medications is linked to a 33% higher risk of serious kidney complications in people with type 2 diabetes. www.labroots.com/trending/dru...
labroots.com
Blood Pressure Drugs Linked to Kidney Risk in Diabetes | Drug Discovery
A commonly prescribed group of blood pressure drugs has been associated with a higher risk of serious kidney problems in people with type 2 diabetes. | Drug Discovery
000
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 17/08/2026
In a 36-week trial, the experimental daily pill aleniglipron helped adults with obesity or overweight achieve up to 12.1% body weight loss. www.labroots.com/trending/dru...
labroots.com
Pill-Based GLP-1 Drug Cuts Weight by Up to 12.1% | Drug Discovery
Aleniglipron helped adults with obesity or overweight lose up to 12.1% of their body weight over 36 weeks. | Drug Discovery
000
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 17/08/2026
Researchers combined generative AI with microbiome analysis to identify 43 key genes tied to Crohn's bowel scarring, enabling earlier detection of tissue damage. www.labroots.com/trending/bio...
labroots.com
Generative AI Helps Spot Crohn's Bowel Scarring Early | Biotech And Pharma
How can generative AI be used to identify and diagnose Crohn’s disease? This is what a recent study published in Frontiers in Artificial Intelligence | Biotech And Pharma
010
Reposted by Labroots Biotech & Pharma Sciences
Labroots @labroots.bsky.social · 03/08/2026
Please be sure to check out our myriad of category pages... ScienceRocks @sciencedoesrock.bsky.social Genetics @genetics-lr.bsky.social Cell & Molecular Biology @cellbiology-lr.bsky.social Immunology & Lymphatic System @immunology-lr.bsky.social Cancer Research @cancer-lr.bsky.social (1/n)
11817
Reposted by Labroots Biotech & Pharma Sciences
Labroots @labroots.bsky.social · 03/08/2026
Cardiology & Circulatory System @cardiology-lr.bsky.social Space & Astronomy @space-lr.bsky.social Health Sciences & Medical Research @healthandmed-lr.bsky.social Technology & Engineering @technology-lr.bsky.social Chemistry & Physics @chemandphys-lr.bsky.social (2/n)
11717
Reposted by Labroots Biotech & Pharma Sciences
Labroots @labroots.bsky.social · 03/08/2026
Biotech & Pharma Sciences @biotech-lr.bsky.social Drug Discovery @drugdiscovery-lr.bsky.social Neuroscience & Nervous System @neuroscience-lr.bsky.social Microbiology @microbiology-lr.bsky.social Nature @nature-lr.bsky.social Earth & Environmental Sciences @earth-lr.bsky.social (3/n)
11817
Reposted by Labroots Biotech & Pharma Sciences
Labroots @labroots.bsky.social · 03/08/2026
Diagnostics & Laboratory Medicine @diagnostics-lr.bsky.social (4/n)
01717
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 03/08/2026
THC aids weight loss, but only full cannabis extract restores the signaling vital for blood-sugar regulation. buff.ly/swsk6G8
buff.ly
Beyond THC: Full Cannabis Extract Improves Glucose Levels | Biotech And Pharma
Multiple compounds in cannabis seem to play a key role in regulating glucose metabolism. | Biotech And Pharma
000
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 31/07/2026
Engineers developed sweat-proof wearable sensors that maintain reliable health tracking even during heavy perspiration. www.labroots.com/trending/bio...
labroots.com
Sweat-Proof Wearable Sensors Offer Better Health Tracking | Biotech And Pharma
How can wearable biosensors be improved to maintain skin contact while still delivering essential health data? This is what a recent study published in Sci | Biotech And Pharma
000
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 30/07/2026
Commercial cannabis markets are linked with higher consumption, not tightly controlled or decriminalised systems. www.labroots.com/trending/can...
labroots.com
Decriminalizing Cannabis Doesn't Increase Cannabis Use | Biotech And Pharma
New research found that decriminalizing personal use of cannabis and tightly controlling the legalization of cannabis don't increase use. | Biotech And Pharma
000
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 30/07/2026
Newer small-molecule GLP-1 drugs may curb pleasure-driven eating—not just hunger. www.labroots.com/trending/dru...
labroots.com
Ozempic in a Pill? Oral GLP-1 Drugs Show Promise in Mice | Drug Discovery
Newer oral drugs related to Ozempic reduce pleasure-driven eating in mice. | Drug Discovery
000
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 27/07/2026
In a mouse model of Alzheimer's disease, inhaled CBD reduced brain inflammation and improved memory-related performance. www.labroots.com/trending/can...
labroots.com
CBD Shows Early Promise for Alzheimer's | Biotech And Pharma
Cannabidiol (CBD) has been shown to reduce brain inflammation in a mouse model of Alzheimer's disease. | Biotech And Pharma
021
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 27/07/2026
Commercial cannabis markets are linked with higher consumption, not tightly controlled or decriminalised systems. www.labroots.com/trending/can...
labroots.com
Decriminalizing Cannabis Doesn't Increase Cannabis Use | Biotech And Pharma
New research found that decriminalizing personal use of cannabis and tightly controlling the legalization of cannabis don't increase use. | Biotech And Pharma
010
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 20/07/2026
A combination of THC and CBD significantly reduced agitation in people with late-stage dementia in a randomized clinical trial. Nearly 9 in 10 treated participants showed improvement after 12 weeks. buff.ly/O03O32L
buff.ly
THC/CBD Reduces Agitation in Late-Stage Dementia | Cannabis Sciences
A combination of THC and CBD significantly reduced agitation in people with late-stage dementia. | Cannabis Sciences
000
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 20/07/2026
A Thai study found that nightly cannabis-infused tea boosted happiness and sleep quality, especially at a 7% concentration. buff.ly/pWVUwZs
buff.ly
Cannabis-Infused Tea Boosts Happiness and Sleep | Cannabis Sciences
How can cannabis-infused tea influence sleep quality and overall quality of life? This is what a recent study published in the Journal of Health Science an | Cannabis Sciences
000
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 17/07/2026
static.klipy.com
Happy Friday Penguin TGIF
ALT: Happy Friday Penguin TGIF
000
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 26/06/2026
A systematic review in Molecules found that topical CBD reduces skin acne and inflammation by up to 40% over 12 weeks. www.labroots.com/trending/can...
labroots.com
Topical CBD Calms Acne Redness | Cannabis Sciences
How can cannabis be used to fight acne and other skin inflammation? This is what a recent study published in the journal Molecules hopes to address as a te | Cannabis Sciences
000
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 22/06/2026
A long-term study indicates that medical cannabis significantly reduces chronic pain and opioid reliance for patients with hypermobility spectrum disorders. www.labroots.com/trending/can...
labroots.com
Medical Cannabis May Offer A Safer and More Effective Treatment for Hypermobility Patients Than Opioids | Cannabis Sciences
A study published in the journal Clinical Rheumatology focused on patients with Ehlers-Danlos syndrome (EDS) and hypermobility spectrum disorders (HSD | Cannabis Sciences
010
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 15/06/2026
An MRI study in Neuropsychopharmacology found that regular adolescent cannabis use alters the dopamine system, reducing brain tissue iron linked to reward and motivation pathways. www.labroots.com/trending/can...
labroots.com
Study Found Teen Cannabis Use Interferes with the Brain's Reward System | Cannabis Sciences
A study published in Neuropsychopharmacology revealed an association between cannabis use during adolescence and differences in brain regions responsible f | Cannabis Sciences
010
Labroots Biotech & Pharma Sciences @biotech-lr.bsky.social · 15/06/2026
While past or occasional cannabis use does not accelerate cognitive decline, active or heavy use is linked to measurable deficits in memory and processing speed. www.labroots.com/trending/can...
labroots.com
Study Compares Cognitive Test Performance of Cannabis Users and Non-Users | Cannabis Sciences
      | Cannabis Sciences
000